Hyperglycemia and reduced adiposity of streptozotocin-induced diabetic mice are not alleviated by oral benzylamine supplementation

Figure 1 Influence of Bza supplementation on body weight gain, food intake and water consumption in normoglycemic and STZ-induced diabetic mice. A: Body weight of diabetic (squares) and nondiabetic mice (circles) drinking water (open symbols) or 0.5% Bza (Bza-drinking, closed symbols). Mean ± SEM of n = 8 males in each group. Significant difference at: ^aP < 0.001 between diabetic and nondiabetic mice, irrespective of the treatment; B: Average daily food intake and water intake. The mean daily consumption calculated throughout the treatment is expressed as g or mL/mouse, for each of the following groups: nondiabetic (white columns), nondiabetic Bza-drinking (red columns), STZ diabetic (yellow columns), STZ diabetic Bza-drinking (black columns). Each column is the mean ± SEM of at least 16 determinations. Different from nondiabetic rats at: ^aP < 0.01. Different from respective control significant at: ^bP < 0.01; ^cP < 0.001. STZ: Streptozotocin; Bza: Benzylamine.